新兴制造商在获取具有公共卫生重要性的创新疫苗方面的作用。
The role of emerging manufacturers in access to innovative vaccines of public health importance.
机构信息
University of Maryland School of Medicine, Geographic Medicine, 685 West Baltimore Street, Baltimore, MD 21201-1509, United States.
出版信息
Vaccine. 2010 Feb 25;28(9):2115-21. doi: 10.1016/j.vaccine.2009.12.036. Epub 2009 Dec 29.
The role of developing country manufacturers in assuring global access to innovative vaccines was compared to the situation in 2005. These producers now supply over 60% of traditional vaccines doses globally and an increasing value (up to 15% in 2007) of innovative products. More suppliers are now strong players in global market, and an even larger group has potential to do so. These manufacturers are not a homogeneous group and most of them are now at a crossroads. Decisions made by their management and governments as well as by the international community will have a large impact on their existence and future and their ability to manufacture innovative vaccines at affordable prices.
发展中国家制造商在确保全球获得创新疫苗方面的作用与 2005 年的情况进行了比较。这些生产商现在提供了全球 60%以上的传统疫苗剂量，并且创新产品的价值（2007 年达到 15%）也在不断增加。更多的供应商现在是全球市场的强劲参与者，甚至有更大的群体也有潜力成为这样的参与者。这些制造商不是一个同质的群体，他们中的大多数现在正处于十字路口。他们的管理层和政府以及国际社会做出的决策将对他们的存在和未来以及他们以可负担的价格制造创新疫苗的能力产生重大影响。
Zotero 插件